Aprea Therapeutics, Inc is a biopharmaceutical company based in Doylestown, PA that is dedicated to revolutionizing cancer treatment through their pioneering approach to synthetic lethality and precision oncology.
With a diversified portfolio of clinical and pre-clinical assets, Aprea Therapeutics develops highly selective DDR-targeted therapeutics that aim to address the unmet medical needs of cancer patients with mutations in DNA damage response genes, while maximizing efficacy and minimizing toxicity.
Generated from the website